Cardinal Health Inc. (CAH)
NYSE: CAHHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CAH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $63.06B
- P/E (TTM)
- 35.29
- Forward P/E
- 18.89
- EPS (TTM)
- $7.73
- Dividend yield
- 0.75% ($2.05)
- Ex-dividend date
- Oct 1, 2026
- 52-week range
- 180.45 – 286.29
- Day range
- 271.98 – 277.72
- Volume / Avg
- 1.98M / 1.72M
- Beta
- —
- Shares outstanding
- 231.14M
52-week range
CAH stock today
Shares of Cardinal Health (CAH) finished higher on Nov 20 at $272.81, a gain of 0.17% or $0.47 per share, versus the S&P 500's 3.70% decline. At this level, CAH sits near the top of its 52-week range of $180.45 to $286.29: 4.7% below the high, set on Nov 5, 2026 and 51.2% above the low. CAH is up 32.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 30.2%.
At 35.3x trailing earnings, Cardinal Health trades above the peer-group median of 18.9x. Its forward P/E of 18.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Cardinal Health pays an annual dividend of $2.05 per share, a 0.75% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Cardinal Health
Company profileCardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Jason M. Hollar
- Headquarters
- Dublin, OH
- Employees
- 58,788
- Website
- cardinalhealth.com
Financial highlights
Full financialsIn fiscal 2026, Cardinal Health generated $254.25 billion in revenue, up 14.2% from fiscal 2025. Net income was $1.71 billion (+9.8% year over year), for a net margin of 0.7% versus a median of 0.4% in the prior 5 years. Gross margin was 3.8% (up from 3.7%) and operating margin 1.0%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Growth | +14.23% | -1.87% | +10.66% | +13.04% | +11.61% |
| Net income | $1.71B | $1.56B | $852.00M | $330.00M | $-938.00M |
| EPS (diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
Analyst forecast
ForecastConsensus (17 analysts)
buy
Avg. price target
$294.87+8.09%
- Strong buy 3
- Buy 11
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $2.38 vs $2.92
- Surprise
- -18.49%
Dividends
Dividend history- Annual dividend
- $2.05
- Dividend yield
- 0.75%
- Last payment
- $0.516
- Ex-dividend date
- Oct 1, 2026
CAH news
All CAH news- Reasons to Add West Pharmaceutical Stock to Your Portfolio NowNasdaqWST, ISRG, CAH, GKOS
- Why Cardinal Health (CAH) is a Top Value Stock for the Long-TermNasdaq
- Zacks.com featured highlights include NVIDIA, J.M. Smucker, Taiwan Semiconductor, Corning, Lockheed and Cardinal HealthNasdaqLMT, NVDA, CAH, GLW
- 5 Dividend Growth Stocks to Buy as NVDA CEO Resignation Rattles MarketNasdaqLMT, CAH, GLW, SJM
- Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?Nasdaq
- Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?Nasdaq
- Cardinal Health Board of Directors Approves Quarterly DividendPR Newswire
- Here's Why Cardinal Health (CAH) is a Great Momentum Stock to BuyNasdaq
Cardinal Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CORCencora Inc. | 339.09 | -0.63% | $64.71B | vs CAH |
| MCKMcKesson Corporation | 1,069.43 | +0.68% | $123.47B | vs CAH |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs CAH |
| NUSNu Skin Enterprises Inc. | 3.80 | +0.80% | $184.98M | vs CAH |
| ESYNEnerSyn Global Inc. | 1.11 | -0.89% | $37.44M | vs CAH |
| COSMCosmos Health Inc. | 2.81 | -2.09% | $14.14M | vs CAH |
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs CAH |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs CAH |
Indexes, lists and sector
Cardinal Health stock FAQ
What is Cardinal Health's stock price today?
CAH last traded at $272.81 as of Nov 20, 4:00 PM EST, up 0.17% on the day. Prices are delayed at least 15 minutes.
Does Cardinal Health pay a dividend?
Yes. Cardinal Health pays $2.05 per share annually, a 0.75% yield. The most recent dividend of $0.516 had an ex-dividend date of Oct 1, 2026.
What is CAH's P/E ratio?
CAH trades at a trailing P/E ratio of 35.29 and a forward P/E of 18.89, compared with a median of 18.9 for its closest peers.
Is Cardinal Health in the S&P 500?
Yes. Cardinal Health (CAH) is a constituent of the S&P 500 index.
Who is Cardinal Health's CEO?
Mr. Jason M. Hollar is the chief executive officer of Cardinal Health Inc., which has about 58,788 employees.
Has CAH ever split its stock?
Yes. The most recent CAH stock split was a 3-for-2 split on Apr 23, 2001, one of 9 splits on record.
What is the CAH 52-week high?
The 52-week high for CAH is $286.29 and the 52-week low is $180.45. The stock is currently 4.7% below its high.